Kevin Haynes, PharmD, MSCE

Associate Director of Epidemiology
Johnson & Johnson

Poster(s):

• (A-202) Active Safety Surveillance Using Real-world Evidence (ASSURE) Implementation: Transparent and Reproducible Real-World Evidence (RWE) Standardized Framework to Support Safety Signal Evaluation
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (B-252) Analyzing Neonatal Mortality: A Systematic Review of Observational Study Approaches
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET